9I制作厂免费

Masad Damha received both his PhD and BSc in Organic Chemistry from 9I制作厂免费. His research is centered on the development of new therapeutic drugs based on RNA targeting and gene editing. With his students, he has authored more than 200 publications, and filed/received several patents worldwide. His proprietary gene silencing and gene editing technologies are being applied by multiple research laboratories and industries to assess and develop modified oligonucleotides against several biological targets, including cancer, infectious and metabolic diseases. Dr. Damha has served as the President of both the International Society of Nucleosides, Nucleotides and Nucleic Acids and the Oligonucleotide Therapeutic Society, and currently serves on the Editorial Board of the journal Nucleic Acids Therapeutics.